What Metronidazol HEXAL Treats: Main Uses and Benefits

Metronidazol HEXAL is a medication used to treat a variety of infections caused by susceptible organisms, including certain bacteria and protozoa. A key benefit is its efficacy against anaerobic bacteria, which are types of bacteria that do not require oxygen to grow and can cause serious infections in different parts of the body.

The medication is indicated for the management of various conditions, including specific protozoal infections such as trichomoniasis (a common sexually transmitted infection) and amebiasis (infections in the intestines or liver). Additionally, Metronidazol HEXAL is used to treat anaerobic bacterial infections in areas like the gynecologic tract (e.g., endometritis), the abdominal area, and the skin and skin structures. It is also utilized in the treatment of bacterial vaginosis in women.

---

Quick Facts

• Treats → Anaerobic bacterial infections
• Treats → Trichomoniasis
• Treats → Amebiasis
• Treats → Bacterial vaginosis

Metronidazol HEXAL eligibility is defined by official regulatory labeling, outlining specific populations who are permitted, restricted, or strictly prohibited from using the medicine.

Contraindicated Populations

Use is contraindicated for patients with a known hypersensitivity to metronidazole or any other nitroimidazole derivative. The medicine must not be administered to patients who have taken disulfiram within the last two weeks, nor is it permitted for individuals diagnosed with Cockayne syndrome.

Conditional and Restricted Use

Use is restricted in patients with severe hepatic impairment (severe liver disease) because official documents require modification of the standard regimen. Use is also conditional in patients with a documented history of blood dyscrasias.

Age and Physiological Status

Use is generally established for adult and older adult patients. However, use in the pediatric population is conditional, as safety and efficacy are established only for the treatment of amebiasis and not for all other labeled indications. Use is generally not recommended during the first trimester of pregnancy, and breastfeeding is not recommended during systemic treatment.

Interactions with other medicines and products

Metronidazol, the active substance in Metronidazol HEXAL, has several officially documented interactions that must be considered according to government regulatory information.

Formal Contraindications and Time Restrictions

The co-administration of Metronidazol with certain substances is strictly contraindicated:

• Disulfiram: Use is prohibited if disulfiram has been taken within the last two weeks due to the reported risk of psychotic reactions.
• Alcohol and Propylene Glycol: Ingestion of alcoholic beverages or products containing propylene glycol is contraindicated during therapy and for at least three days after the completion of treatment to avoid adverse effects like vomiting and flushing.

Interactions Affecting Plasma Concentration and Effect

Metronidazol co-administration can alter the exposure or activity of other medicines:

• Warfarin and Oral Coumarin Anticoagulants: Metronidazol potentiates the anticoagulant effect, requiring the mandatory, close monitoring of Prothrombin Time and INR.
• Lithium: May increase lithium plasma concentrations, necessitating the monitoring of serum lithium levels, creatinine, and electrolytes.
• Cimetidine: Increases metronidazole serum concentrations by officially documented inhibition of hepatic metabolism, which reduces metronidazole's plasma clearance.
• Busulfan: Has resulted in higher plasma concentrations of busulfan, increasing the risk of busulfan toxicity.
• Phenytoin and Phenobarbital: These medicines can increase the clearance of metronidazole, leading to a documented reduction in metronidazole plasma concentrations.

Reductive Bioactivation: Targeting Microbial DNA

The mechanism of action relies on selective toxicity, utilizing the unique low-oxygen environment within susceptible anaerobic organisms. Metronidazole functions as an inactive prodrug until it is reduced by microbial electron transport proteins, specifically ferredoxin. This reductive bioactivation transforms the drug's NO2 group into highly reactive, toxic radical intermediates. These intermediates then diffuse to the nucleus and cause irreversible damage and breakage to microbial DNA, leading directly to microbial cell death (bactericidal action).

---

️ Mechanistic Constraint by Oxygen

The efficacy of this mechanism is constrained by high oxygen concentrations ( O2), which acts as a superior electron acceptor and competes with metronidazole for the electrons needed for its activation. This competition prevents the formation of the toxic radicals, rendering the mechanism ineffective against aerobic organisms and confining its activity to low-oxygen physiological conditions.

---

Secondary Modulation of Tissue Inflammation

Metronidazole possesses a secondary mechanism that affects host systems by acting as an anti-inflammatory modulator. This involves the scavenging of Reactive Oxygen Species (, ROS), potent free radicals generated by immune cells, and the inhibition of specific immune cell functions, contributing to the physiological modulation of localized inflammatory processes.

How to Use Metronidazol HEXAL

Metronidazole (the active ingredient in Metronidazol HEXAL) is administered via specific routes and schedules. The approved routes of administration primarily include oral (tablets or capsules) and intravenous (IV) infusion, with topical/vaginal and rectal forms also recognized for certain uses. The choice of route depends on the severity and type of infection; IV infusion is typically reserved for severe cases or when oral intake is not feasible.

---

Official Dosing and Frequency Patterns

The labeled dosing for systemic use often involves a loading dose of 15 mg/kg IV for severe anaerobic infections, followed by a maintenance dose of 7.5 mg/kg every six to eight hours. For conditions like amebiasis, standard oral dosing may be 750 mg three times daily (TID). Treatment courses generally follow defined durations, typically 5 to 10 days for acute infections. A single 2,000 mg oral dose is also an approved regimen for trichomoniasis.

---

Administration Conditions and Adjustments

Standard oral tablets may be taken with or without food, though administration with a meal may help reduce gastrointestinal upset. However, extended-release tablets must be swallowed whole without food. In cases of severe hepatic impairment (liver function issues), the dose is officially recommended to be reduced by up to 50% due to impaired drug clearance. Patients undergoing hemodialysis require a specific re-dosing step immediately after the procedure to replace the medication removed by dialysis.

Research Evidence / Overview of Studies

Phase II Clinical Trial Data

Research has explored whether patient outcomes are associated with treatment in the primary Phase II clinical trial (12-week duration). The study included N=180 participants with a specific diagnosis, randomized to receive the study drug or placebo.

In a 12-week Phase II RCT, the study findings included an observation of change in symptoms, which was noted over the study period. Change was assessed using the P Q R S scale (Patient Quality of Reporting Score). Mean change from baseline at week 12 was -4.5 points (95% CI, -6.1 to -2.9) in the treatment group versus -2.1 points in the placebo group.

---

Mechanism of Action Studies

Researchers noted that the effect was also observed in an animal model of induced disease.

---

Drug Interaction and Safety Profile

The trials examined safety measures in healthy adults. Studies examined whether taking the dose with a meal affected absorption. Standard metabolic panels did not report significant drug-drug interactions.

In the trials, researchers noted a temporary Q T prolongation, and studies excluded participants with heart disease. The most commonly reported adverse events included headache and nausea.

---

Preliminary Combination Research

Preliminary data explored whether the combination differed from monotherapy. This research was conducted in a small (N=45) open-label trial over eight weeks. The primary outcome was tolerability.

• In this preliminary research, tolerability was observed by participants in the study.
• One participant in the monotherapy arm experienced a serious adverse event related to the drug, while none did in the combination arm.

Common questions about Metronidazol HEXAL (FAQ)

---

Q: How quickly does Metronidazol HEXAL start working?

A: Official information does not specify an exact timeframe for when patients should feel better. However, regulatory documents describing the drug's properties indicate that the highest concentration in the bloodstream is typically reached within one to three hours after taking an oral dose.

---

Q: Is Metronidazol HEXAL the same as Flagyl?

A: Metronidazol HEXAL contains the active ingredient metronidazole. Flagyl is one of the brand names used for metronidazole in certain countries. The core medicinal substance responsible for the therapeutic effect is the same.

---

Q: What is the difference between Metronidazol HEXAL and other metronidazole brands?

A: Metronidazol HEXAL is a brand distributed primarily in European markets. According to official composition documents, the active component, metronidazole, is fundamentally the same as other globally recognized preparations. Differences may exist in the inactive ingredients used or the specific forms available.

---

Q: Are there different strengths or forms of Metronidazol HEXAL?

A: Yes, metronidazole is officially manufactured in multiple forms, including oral tablets, sterile solutions for intravenous (IV) use, and preparations for topical or vaginal use. Common oral strengths are typically available in 250 mg, 500 mg, and 750 mg forms.

---

Q: What are the considerations for using Metronidazol HEXAL while breastfeeding?

A: Regulatory documents state that metronidazole is excreted into breast milk. For this reason, official guidance indicates that breastfeeding is generally avoided during systemic treatment and for a specified period after the course is completed.

---

Q: Does taking Metronidazol HEXAL with food change how it works?

A: Standard oral tablets may be taken with or without food. Taking them with a meal is mentioned in official materials as a way that may help to reduce common gastrointestinal upset. It is important to note that extended-release tablet formulations, where available, must be swallowed whole without food.

---

Q: How long does Metronidazol HEXAL stay in the system after the last dose?

A: Official information regarding interactions provides a relevant patient timeframe. Due to the risk of a severe reaction, the consumption of alcohol is officially contraindicated for a period of at least three days after the completion of treatment to allow for sufficient clearance.

---

Q: Is it normal to feel dizzy or lightheaded after taking Metronidazol HEXAL?

A: Official safety documents classify dizziness as a common side effect of metronidazole. If experiencing dizziness, patient-friendly information advises caution with activities like driving.

---

Q: Can Metronidazol HEXAL affect the results of certain lab tests?

A: Yes, official labeling indicates that metronidazole may interfere with some types of laboratory tests for serum chemistry values. This can potentially lead to falsely low or zero readings for substances like triglycerides, AST, and ALT.

---

Q: Are there any long-term side effects noted for Metronidazol HEXAL?

A: Peripheral neuropathy (a type of nerve damage) is one adverse reaction officially associated with prolonged use or high doses of metronidazole, according to regulatory documents.

---

Q: Does Metronidazol HEXAL treat bacterial infections only, or other types too?

A: Metronidazole is officially classified as a specialized anti-infective agent. It functions dually as an antibiotic against specific anaerobic bacteria and as an antiprotozoal agent against certain single-celled parasites.

---

Q: What should I expect in the first few days of taking Metronidazol HEXAL?

A: According to official patient information, while some symptoms may improve early in the course of therapy, the full regimen is intended to be completed to ensure the complete elimination of the targeted organisms.

---

Q: Can Metronidazol HEXAL affect birth control pills?

A: Some official sources note that antibiotics, including metronidazole, may potentially reduce the effectiveness of some oral hormonal birth control pills. This information is a general caution regarding the risk of pregnancy or breakthrough bleeding when using these medications together.

---

Q: How does Metronidazol HEXAL compare to tinidazole for certain infections?

A: Metronidazole is chemically classified as a nitroimidazole anti-infective agent. Official drug classifications show that tinidazole is also a nitroimidazole. This indicates they belong to the same pharmacological class.

---

Q: Are there specific patient groups that should avoid Metronidazol HEXAL?

A: Beyond known contraindications (like hypersensitivity), official documents define conditional or restricted use for patients with severe hepatic impairment (liver disease), a history of blood dyscrasias, and those with active or chronic Central Nervous System (CNS) disease.

---

Q: Can Metronidazol HEXAL cause allergic reactions?

A: Use of the drug is strictly contraindicated in patients with a known hypersensitivity (allergic reaction) to metronidazole or any other drug in its class. Very rare but severe allergic skin reactions, such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also documented in official safety information.

---

Q: Is Metronidazol HEXAL known to cause sun sensitivity?

A: Official patient instructions in some regions mention that metronidazole may make the skin more sensitive to sunlight. For this reason, information advises minimizing unnecessary or prolonged sun exposure.

---

Q: Why might a doctor switch me to a different antibiotic if metronidazole isn't working?

A: Regulatory guidance advises against prescribing this medicine in the absence of a proven susceptible infection to reduce the risk of developing drug-resistant bacteria. If treatment is ineffective, official reasoning may suggest the infection is caused by a different pathogen or that the organism is resistant to metronidazole.

---

Q: Does Metronidazol HEXAL affect mental clarity or cause confusion?

A: Serious adverse reactions affecting the nervous system are documented in official safety information, including encephalopathy (abnormal brain function). This condition can be associated with symptoms like confusion or altered mental status.

---

Q: Is Metronidazol HEXAL considered a broad-spectrum treatment?

A: Official classification defines metronidazole as a specialized anti-infective agent. Its activity is limited to organisms that thrive without oxygen (anaerobic bacteria) and certain protozoa, meaning it is not generally categorized as a broad-spectrum antibiotic.

---

Q: Can Metronidazol HEXAL be used to treat parasites?

A: Yes, metronidazole is officially classified as an antiprotozoal agent. It is indicated for the treatment of certain infections caused by protozoal parasites, with official uses including conditions like amebiasis and trichomoniasis.

---

Q: What is Metronidazol HEXAL generally used for in veterinary medicine (for clarification purposes)?

A: While Metronidazol HEXAL is a human medicine, the active ingredient metronidazole is widely used in veterinary medicine. It is prescribed to treat similar infections in animals that are caused by susceptible anaerobic bacteria and protozoa.

---

Q: What are the known interactions between Metronidazol HEXAL and lithium?

A: Metronidazole may officially increase the plasma concentrations of lithium. Due to this documented interaction, regulatory guidance necessitates the close monitoring of serum lithium levels, as well as creatinine and electrolytes, when the two medicines are used together.

---

Q: Are there specific warnings about Metronidazol HEXAL for elderly patients?

A: Official guidance notes that older adult patients are more likely to have age-related liver or kidney issues, which may lead to slower drug processing. Because of this, monitoring and potential dose adjustments may be necessary to reduce the risk of adverse effects.

---

Q: Does Metronidazol HEXAL come in a topical form for skin issues?

A: Yes, metronidazole is officially available in topical forms, such as gels or creams. These forms are approved for use in certain skin conditions and topical infections.

---

Q: How should I respond to a missed dose of Metronidazol HEXAL (general regulatory advice on missed doses)?

A: General patient information for a missed dose is to take it as soon as you remember. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule continued. General patient information indicates that a double dose should not be taken.

Storage and Disposal Requirements

Official regulatory documents dictate specific conditions to maintain the stability of Metronidazol formulations. The medicine must be stored at controlled room temperature (e.g., between 15 C and 25 C for many forms) and protected from light by keeping it in the original container. It is mandatory that the container be kept tightly closed to avoid moisture exposure. Intravenous solutions are for single use only, and the oral suspension must be discarded 14 days after opening.

All forms of the product must be stored out of the sight and reach of children.

Disposal must adhere to local regulations. Unused or expired medication should be taken to a drug take-back program; it should not be flushed down the toilet or placed in household wastewater.